Attached files
| file | filename |
|---|---|
| EX-32.2 - Yubo International Biotech Ltd | e616278_ex32-2.htm |
| EX-31.2 - Yubo International Biotech Ltd | e616278_ex31-2.htm |
| EX-31.1 - Yubo International Biotech Ltd | e616278_ex31-1.htm |
| EX-10.48 - Yubo International Biotech Ltd | e616278_ex10-48.htm |
| EX-10.47 - Yubo International Biotech Ltd | e616278_ex10-47.htm |
| EX-10.46 - Yubo International Biotech Ltd | e616278_ex10-46.htm |
| EX-10.45 - Yubo International Biotech Ltd | e616278_ex10-45.htm |
| EX-10.44 - Yubo International Biotech Ltd | e616278_ex10-44.htm |
| EX-10.43 - Yubo International Biotech Ltd | e616278_ex10-43.htm |
| EX-10.42 - Yubo International Biotech Ltd | e616278_ex10-42.htm |
| 10-K - Yubo International Biotech Ltd | e616278_10k-magna.htm |
EXHIBIT 32.1: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Annual Report on Form 10-K of Magna-Lab, Inc. for the year ended February 28, 2017, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
| (1) | such Annual Report on Form 10-K for the year ended February 28, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in such Annual Report on Form 10-K for the year ended February 28, 2017 fairly presents, in all material respects, the financial condition and results of operations of Magna-Lab, Inc. |
| June 14, 2017 | /s/ Lawrence A. Minkoff Name: Lawrence A. Minkoff Title: Chairman, President (principal executive officer) |